<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01641185</url>
  </required_header>
  <id_info>
    <org_study_id>IPI</org_study_id>
    <nct_id>NCT01641185</nct_id>
  </id_info>
  <brief_title>Ion Prostate Irradiation</brief_title>
  <acronym>IPI</acronym>
  <official_title>Hypofractionated Ion Irradiation (Carbon Ions Versus Protons) of the Prostate</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Heidelberg University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Heidelberg University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the safety and feasibility of primary
      hypofractionated irradiation of the prostate with carbon ions or protons using the raster
      scan technique.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      as published: Habl G, Hatiboglu G, Edler L, Uhl M, Krause S, Roethke M, Schlemmer HP,
      Hadaschik B, Debus J, Herfarth K: Ion Prostate Irradiation (IPI) - a pilot study to establish
      the safety and feasibility of primary hypofractionated irradiation of the prostate with
      protons and carbon ions in a raster scan technique. BMC cancer 2014, 14(1):202.

      http://www.ncbi.nlm.nih.gov/pubmed/24641841
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2012</start_date>
  <completion_date type="Actual">December 2015</completion_date>
  <primary_completion_date type="Actual">December 2015</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>proctitis and cystitis</measure>
    <time_frame>3 years</time_frame>
    <description>via incidence grade 3-4 toxicity (NCI-CTC-AE)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>PSA-PFS</measure>
    <time_frame>3 years</time_frame>
    <description>by measuring PSA values every 3 months</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>OS</measure>
    <time_frame>3 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>quality of life</measure>
    <time_frame>3 years</time_frame>
    <description>by questionnaire</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">92</enrollment>
  <condition>Prostatic Neoplasms</condition>
  <arm_group>
    <arm_group_label>protons</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>irradiation 20 x 3,3 GyE protons</description>
  </arm_group>
  <arm_group>
    <arm_group_label>carbon ions</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>irradiation 20 x 3,3 GyE carbon ions</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>radiation</intervention_name>
    <description>radiation with protons or carbon ions</description>
    <arm_group_label>protons</arm_group_label>
    <arm_group_label>carbon ions</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        histological proven carcinoma of the prostate with Gleason score risk of lymphe node
        involvement of &lt;15% calculated by the Yale-formula; Risk [%] = [GS -5] x [PSA/3 + 1.5 x T],
        mit T = 0, 1, and 2 for cT1c, cT2a, und cT2b/cT2c

          -  Karnofsky-Index â‰¥ 70%

          -  age between 40 and 80 years

          -  PSA

        Exclusion Criteria:

        Stadium IV (distant metastases) Lymphogenous Metastases hip replacement former irradiation
        of the pelvis pacemaker defibrillator
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Klaus Herfarth, Prof. Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital of Heidelberg</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Heidelberg, Radiooncology, HIT</name>
      <address>
        <city>Heidelberg</city>
        <zip>69120</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Habl G, Hatiboglu G, Edler L, Uhl M, Krause S, Roethke M, Schlemmer HP, Hadaschik B, Debus J, Herfarth K. Ion Prostate Irradiation (IPI) - a pilot study to establish the safety and feasibility of primary hypofractionated irradiation of the prostate with protons and carbon ions in a raster scan technique. BMC Cancer. 2014 Mar 19;14:202. doi: 10.1186/1471-2407-14-202.</citation>
    <PMID>24641841</PMID>
  </reference>
  <reference>
    <citation>Habl G, Uhl M, Katayama S, Kessel KA, Hatiboglu G, Hadaschik B, Edler L, Tichy D, Ellerbrock M, Haberer T, Wolf MB, Schlemmer HP, Debus J, Herfarth K. Acute Toxicity and Quality of Life in Patients With Prostate Cancer Treated With Protons or Carbon Ions in a Prospective Randomized Phase II Study--The IPI Trial. Int J Radiat Oncol Biol Phys. 2016 May 1;95(1):435-43. doi: 10.1016/j.ijrobp.2016.02.025. Epub 2016 Feb 12.</citation>
    <PMID>27084659</PMID>
  </reference>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 6, 2012</study_first_submitted>
  <study_first_submitted_qc>July 13, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 16, 2012</study_first_posted>
  <last_update_submitted>May 1, 2017</last_update_submitted>
  <last_update_submitted_qc>May 1, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 4, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Heidelberg University</investigator_affiliation>
    <investigator_full_name>Klaus Herfarth, MD</investigator_full_name>
    <investigator_title>Prof. Dr. Herfarth</investigator_title>
  </responsible_party>
  <keyword>prostate</keyword>
  <keyword>IPI</keyword>
  <keyword>hypofractionation</keyword>
  <keyword>carbon ions</keyword>
  <keyword>proton</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prostatic Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

